| 000 | 01570 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515185356.0 | ||
| 264 | 0 | _c20101025 | |
| 008 | 201010s 0 0 eng d | ||
| 022 | _a1573-4978 | ||
| 024 | 7 |
_a10.1007/s11033-009-9801-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Zhi-Hua | |
| 245 | 0 | 0 |
_aThe growth-inhibition effect of tamoxifen in the combination chemotherapeutics on the human cholangiocarcinoma cell line QBC939. _h[electronic resource] |
| 260 |
_bMolecular biology reports _cJul 2010 |
||
| 300 |
_a2693-701 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCholangiocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aDoxorubicin _xpharmacology |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracellular Space _xdrug effects |
| 650 | 0 | 4 |
_aTamoxifen _xpharmacology |
| 650 | 0 | 4 |
_abcl-2-Associated X Protein _xgenetics |
| 700 | 1 | _aHe, Yan-Ping | |
| 700 | 1 | _aQin, Huanlong | |
| 773 | 0 |
_tMolecular biology reports _gvol. 37 _gno. 6 _gp. 2693-701 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11033-009-9801-2 _zAvailable from publisher's website |
| 999 |
_c19154887 _d19154887 |
||